Search

everythinglearnresearchcommunity

for

Search:↓

Advancements in hair biology include new treatments and tools for hair growth and alopecia.

The meeting covered advances in understanding hair growth, causes of hair loss, and potential treatments.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Eclipta alba has many health benefits and contains compounds with potential for drug development.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Antidepressants might help with skin inflammation and improve conditions like psoriasis and eczema.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Treating alopecia areata every 3 weeks with diphenylcyclopropenone is more effective than weekly treatments.

The DiLiCre mouse model is an effective tool for precise genome editing using light.

Malassezia furfur lipids improve skin health at pH 6.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

Children with alopecia areata often have vitiligo, allergic asthma, ADHD, and low vitamin B12 and ferritin levels.

Amla is a nutritious fruit with many health benefits, including boosting immunity and fighting diseases.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.